Abstract
Interpolymer complexes (IPC) based on Eudragit® EPO and Eudragit® S100were investigated as potential carriers for oral controlled drug delivery to the colon. IPC samples were prepared by mixing copolymer solutions in organic solvents (ethanol, isopropanol:acetone mixture (60:40, % v/v) and tetrahydrofuran). According to the data of elemental analysis, FTIR-spectroscopy, X-ray photoelectron spectroscopy and thermal analysis these IPCs have excess of anionic copolymer (Eudragit® S100) in their structure; they are stabilized by hydrogen and ionic intermacromolecular bonds and do not include free copolymer domains. IPC have pH-independent swelling properties in the media mimicking gastrointestinal tract (GIT) conditions and provide colon-specific delivery of indomethacin in buffer solutions (pH 1.2; 5.8; 6.8; 7.4) and in biorelevant media (fasted state simulated gastric fluid, fasted state simulated intestinal fluid-version 2 and fasted stated simulated colonic fluid).
Author supplied keywords
Cite
CITATION STYLE
Bukhovets, A. V., Fotaki, N., Khutoryanskiy, V. V., & Moustafine, R. I. (2020). Interpolymer complexes of eudragit® copolymers as novel carriers for colon-specific drug delivery. Polymers, 12(7), 1–16. https://doi.org/10.3390/polym12071459
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.